Figure 5

Synergistic treatments. (a) Treatment BCIs calculated between the corresponding column and row label. BCIs of the most synergistic treatments among all (NK + AM) and the most synergistic treatments relative to androgen deprivation (CX + ICB) have been highlighted in bold. (b) Tumor inhibition rate of CX and ICB as monotherapies, of ICB and CX interacting as a dual-therapy, of ICB and CX not interacting as they were delivered separately, and of ICB half-dosage and CX interacting as a dual-therapy.